(Q52881905)

9 May 2018

title

Use of the mitotic counts for the prognosis and grading of breast cancer. Method evaluation study. (English)

1 reference

9 May 2018

author name string

Kujari HP

series ordinal

1

1 reference

9 May 2018

Collan YU

series ordinal

2

1 reference

9 May 2018

Atkin NB

series ordinal

3

1 reference

9 May 2018

publication date

1 June 1994

1 reference

9 May 2018

Pathology, Research and Practice

published in

1 reference

9 May 2018

volume

190

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

page(s)

593-599

1 reference

9 May 2018

The value of morphometry to classic prognosticators in breast cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

General principles of grading lesions in diagnostic histopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

The value of mitotic counting in the assessment of prognosis and proliferation in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Mitosis counting--a need for reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Prognosis of ovarian carcinomas: prediction by histoquantitative methods

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

The cell-proliferative index

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Nucleolar organiser regions: new prognostic variable in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Delay in fixation does not affect the immunoreactivity of proliferating cell nuclear antigen (PCNA)

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

AgNOR counts have no prognostic value in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

Improved flow cytometric determination of proliferative activity (S-phase fraction) from paraffin-embedded tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980397-3

7 January 2021

10.1016/S0344-0338(11)80397-3

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018